Drug Database · Clinicians

Guiafenesin

Also known as: guaifenesin (international nonproprietary name and US name and British name) · guaiphenesin (former British name)

Brands (2) Bronchosaph-100, Com-LidondeShow all

This entry appears to be Guaifenesin registered under a variant spelling.

See the main Guaifenesin monograph (kidney dosing, prescribing information, all brands) →

US brand (reference label): Childrens Mucus Relief Chest Congestion; not a Philippine-registered brand.

Expectorant US FDA class
Expectorant PH FDA category

OTC · Over-the-counter2 PH products
Dispensing: Over-the-counter (OTC) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID 034d39c0-9aad-4dff-a158-a041b9f0504f, version date October 30, 2026 (Childrens Mucus Relief Chest Congestion · Chain Drug Manufacturing Assn). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • Uses helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
US FDA label
Full indications and usage US FDA label

Uses helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

Dosing: Adult

Dosage and administration (US label) US FDA label

Directions ▪ do not take more than 6 doses in any 24-hour period ▪ measure only with dosing cup provided ▪ do not use dosing cup with other products ▪ mL = milliliter Age Dose children 6 years to under 12 years 5 mL – 10 mL every 4 hours children 4 years to under 6 years 2.5 mL – 5 mL every 4 hours children under 4 years do not use

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Syrup: 100 mg/5 mL

Registered products in the Philippines

2 products registered with the Food and Drug Administration (FDA) Philippines list Guiafenesin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Guiafenesin
Package insert
Bronchosaph-100Guiafenesin
100 mg/5 mL SyrupPET Round Amber Bottle with ROPP Aluminum Cap x 60 mL and 120 mL (Box of 1's)
OTC
Enicar Pharmaceuticals Pvt. Ltd.India
Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd.
DRP-9428
Sep 9, 2031
Com-LidondeGuiafenesin
100 mg/5 mL Syrup60 mL Amber Glass Bottle
OTC
Compact Pharmaceuticals, Corp.Philippines
—
DR-XY1852
Jan 14, 2028

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Warnings/Precautions

Warnings and precautions (US label) US FDA label

Warnings Ask a doctor before use if the child has ▪ cough that occurs with too much phlegm (mucus) ▪ persistent or chronic cough such as occurs with asthma Stop use and ask a doctor if cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. Childrens Mucus Relief Chest Congestion · Chain Drug Manufacturing Assn [US FDA-approved label, version 9, October 30, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=034d39c0-9aad-4dff-a158-a041b9f0504f
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .